Showing results (101-110 of 355) with videos related to
Sort By:
Pageof 36
JAMA Cardiology|April 5, 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialAlvin Chandra, Eldrin F Lewis, Brian L Claggett, et al.Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.European Journal of Heart Failure|April 8, 2024
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HFShingo Matsumoto, Mingming Yang, Li Shen, et al.Journal of the American College of Cardiology|November 15, 2019
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEFMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.Circulation|May 25, 2021
Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart AssociationAndrew D Althouse, Jennifer E Below, Brian L Claggett, et al.European Journal of Heart Failure|May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trialBrendon L Neuen, Henri Lu, Muthiah Vaduganathan, et al.Circulation. Heart Failure|October 4, 2014
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696Pardeep S Jhund, Brian L Claggett, Adriaan A Voors, et al.European Journal of Heart Failure|June 8, 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trialAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.European Heart Journal|March 28, 2026
Lipoprotein(a) and incident venous thromboembolism in pre- and postmenopausal women, and in menDaniel Ezzat, Diana M Lopez, Brian L Claggett, et al.JAMA Cardiology|August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.Pageof 36